Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective
Summary
Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective is a scholarly article[1].
Key Facts
Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective. Retrieved May 24, 2026, from https://4ort.xyz/entity/evaluating-the-cost-effectiveness-of-secukinumab-in-moderate-to-severe-psoriasis-a-japanese-perspective
MLA“Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/evaluating-the-cost-effectiveness-of-secukinumab-in-moderate-to-severe-psoriasis-a-japanese-perspective.
BibTeX@misc{4ortxyz_evaluating-the-cost-effectiveness-of-secukinumab-in-moderate-to-severe-psoriasis-a-japanese-perspective_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective}}, year = {2026}, url = {https://4ort.xyz/entity/evaluating-the-cost-effectiveness-of-secukinumab-in-moderate-to-severe-psoriasis-a-japanese-perspective}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective — https://4ort.xyz/entity/evaluating-the-cost-effectiveness-of-secukinumab-in-moderate-to-severe-psoriasis-a-japanese-perspective (retrieved 2026-05-24)
